Loading chat...

NY S00036

Bill

Official Source

Status

Passed

2/3/2025

Primary Sponsor

Shelley Mayer

Click for details

Origin

Senate

2025-2026 General Assembly

AI Summary

  • Allows prescription labels for mifepristone, misoprostol, and generic equivalents to display the dispensing health care practice name instead of the individual dispenser's name
  • Permits prescribers to request that their health care practice name appear on the label rather than their personal name
  • Applies specifically to abortion medications (mifepristone and misoprostol), potentially providing privacy protection for prescribers and dispensers
  • Takes effect immediately upon passage
  • Introduced by Senators Mayer, Myrie, and Rivera and referred to the Committee on Higher Education

Legislative Description

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Last Action

APPROVAL MEMO.1

2/3/2025

Committee Referrals

Higher Education1/21/2025
Rules1/21/2025
Higher Education1/8/2025

Full Bill Text

No bill text available